JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lau, C. E.
Right arrow Articles by Falk, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, C. E.
Right arrow Articles by Falk, J. L.

Vol. 281, Issue 3, 1013-1029, 1997

Differential Reinforcement of Low Rate Performance, Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Modeling: Independent Interaction of Alprazolam and Caffeine1

Chyan E. Lau, Yunxia Wang and John L. Falk

Department of Psychology, Rutgers University, New Brunswick, New Jersey

To investigate the interaction between alprazolam and caffeine, performance on a differential reinforcement of low-rate behavior schedule and the respective pharmacokinetics (PK) were explored in concurrent studies. Alprazolam PK was not altered by caffeine, but alprazolam retarded caffeine absorption indirectly, as inferred by the lack of i.v. drug administration PK interaction, thereby decreasing serum methylxanthine concentrations. Inasmuch as alprazolam was more potent and short-lived than caffeine in decreasing the reinforcement rate (consonant with their respective t1/2 values, 0.44 and 3.1 hr), the alprazolam/caffeine potency ratio decreased across the session time, which determined the expression of the combined effects. Thus, the decreased methylxanthine level yielded slightly less disruption in performance for the observed combined effect, compared to the expected calculated effect, only near the end of a session. The interaction was PK linked and mainly not distinguishable from independence as indicated by the Pöch dose-response curve method and the integration of PK and pharmacodynamics. The sigmoid maximal effect-link pharmacodynamic model indicated that caffeine did not alter the concentration at half of the maximal effect value of alprazolam and suggested that the interaction is not competitive, but independent. Although the nature of the benzodiazepine-methylxanthine interaction has been controversial in other behavioral studies, as is the role of PK in determining behavior, this and our previous study make it evident that the interaction is independent not only across doses and routes of administration, but also with respect to two indices of differential reinforcement of low rate performance.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. S. Park, H. J. Jun, M. J. Cho, K. H. Cho, J. S. Lee, J. I. Zo, and H. Pyo
Radiosensitivity Enhancement by Combined Treatment of Celecoxib and Gefitinib on Human Lung Cancer Cells.
Clin. Cancer Res., August 15, 2006; 12(16): 4989 - 4999.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Lau, L. Sun, Q. Wang, A. Simpao, and J. L. Falk
Oral Cocaine Pharmacokinetics and Pharmacodynamics in a Cumulative-Dose Regimen: Pharmacokinetic-Pharmacodynamic Modeling of Concurrent Operant and Spontaneous Behavior within an Operant Context
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 634 - 643.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
Y. Wang, A. Roy, L. Sun, and C. E. Lau
Short Communication: A Double-Peak Phenomenon in the Pharmacokinetics of Alprazolam after Oral Administration
Drug Metab. Dispos., August 1, 1999; 27(8): 855 - 859.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Lau, F. Ma, D. M. Foster, and J. L. Falk
Pharmacokinetic-Pharmacodynamic Modeling of the Psychomotor Stimulant Effect of Cocaine after Intravenous Administration: Timing Performance Deficits
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 535 - 543.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Lau and A. C. Heatherington
Pharmacokinetic-Pharmacodynamic Modeling of Stimulatory and Sedative Effects of Alprazolam: Timing Performance Deficits
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1119 - 1129.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.